# A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients

> **NCT01946009** · NA · COMPLETED · sponsor: **Fundacion SEIMC-GESIDA** · enrollment: 20 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Cidofovir 1% cream's basis, 2gr, three times per week, during 4 weeks.

## Key facts

- **NCT ID:** NCT01946009
- **Lead sponsor:** Fundacion SEIMC-GESIDA
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01946009

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01946009, "A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01946009. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*